Literature DB >> 22440314

Intravenous boluses of fentanyl, 1 μg kg⁻¹, and remifentanil, 0.5 μg kg⁻¹, give similar maximum ventilatory depression in awake volunteers.

J Gelberg1, C Jonmarker, O Stenqvist, O Werner.   

Abstract

BACKGROUND: The relative respiratory effects of fentanyl and remifentanil, administered as i.v. bolus, have not previously been studied. We determined what remifentanil bolus dose gave the same maximum depression of ventilation as 1 µg kg(-1) of fentanyl.
METHODS: Twelve healthy volunteers rebreathed in a system designed to dampen variations in end-tidal carbon dioxide tension PE'CO2 so that measurements would be obtained at similar levels of CO(2) stimulation. The minute ventilation was measured before (V(preinj)) and after injection (V(nadir)) of fentanyl, 1 µg kg(-1), and remifentanil, 0.25, 0.5, and 1 µg kg(-1). The remifentanil doses were plotted against V(nadir)/V(preinj) in a log-probit diagram to determine what amount gave the same maximum ventilatory depression as the fentanyl dose.
RESULTS: V(nadir) was [median (inter-quartile range)] 51 (38-64)% of V(preinj) after fentanyl, and 70 (61-77), 50 (46-56), and 29 (24-38)%, respectively, after remifentanil. The nadir occurred 5.0 (4.4-7.0) min after fentanyl, and 3.8 (2.7-4.6), 2.9 (2.7-3.2), and 3.0 (2.7-3.2) min after remifentanil injection. PE'CO2 at ventilation nadir was 6.26 (5.98-6.62) kPa after fentanyl, and 6.18 (6.12-6.50), 6.11 (5.91-6.45), and 6.11 (5.93-6.45) kPa after remifentanil 0.25, 0.5, and 1 µg kg(-1), respectively. A remifentanil dose of 0.47 (0.42-0.62) µg kg(-1) was equidepressant to 1 µg kg(-1) of fentanyl. Fifteen minutes after fentanyl injection, the median minute ventilation was 30-40% less than after injection of remifentanil, 0.25 and 0.5 µg kg(-1) (P<0.05).
CONCLUSIONS: Fentanyl, 1 µg kg(-1), and remifentanil, 0.5 µg kg(-1), gave similar maximum ventilatory depression. The onset of and recovery from ventilatory depression were faster with remifentanil.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440314     DOI: 10.1093/bja/aes029

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

Review 1.  Remifentanil: applications in neonates.

Authors:  Mineto Kamata; Joseph D Tobias
Journal:  J Anesth       Date:  2016-01-13       Impact factor: 2.078

2.  Continuous Positive Airway Pressure Mitigates Opioid-induced Worsening of Sleep-disordered Breathing Early after Bariatric Surgery.

Authors:  Sebastian Zaremba; Christina H Shin; Matthew M Hutter; Sanjana A Malviya; Stephanie D Grabitz; Teresa MacDonald; Daniel Diaz-Gil; Satya Krishna Ramachandran; Dean Hess; Atul Malhotra; Matthias Eikermann
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

3.  Evaluation of the brain anaesthesia response monitor during anaesthesia for cardiac surgery: a double-blind, randomised controlled trial using two doses of fentanyl.

Authors:  Mehrnaz Shoushtarian; Desmond P McGlade; Louis J Delacretaz; David T J Liley
Journal:  J Clin Monit Comput       Date:  2015-09-25       Impact factor: 2.502

4.  High-dose remifentanil increases blood pressure and heart rate mediated by sympatho-activation in conscious rats.

Authors:  Tetsuro Shirasaka; Takeshi Yano; Takato Kunitake; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2012-11-07       Impact factor: 2.078

5.  Assessment of awake i-gel™ insertion for fiberoptic-guided intubation in patients with predicted difficult airway: A prospective, observational study.

Authors:  Julian Arevalo Ludeña; Jose Juan Arcas Bellas; Rafael Alvarez Rementeria; Luis Enrique Muñoz Alameda
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.